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Mutagenicity
McDiarmid, Oliver, Roth, Rogers, and Escalante (2010) examined damage to chromosomes 5, 7, and 11 in 109 hospital employees. These chromosomes were selected for analysis because they have been associated with therapy-related acute myeloid leukemia (Pedersen-Bjergaard, Andersen, Christiansen, & Nerlov, 2002; Rogers & Emmett, 1987) . The study cohort included 63 oncology nursing and pharmacy employees, and 46 employees who did not handle HDs as a control group. Damage was detected on chromosomes 5 and 7 more often in staff who handled HDs versus those who did not (p = 0.01). The study also demonstrated that increased damage was associated with increased handling, particularly with alkylating agents, such as cyclophosphamide (Cytoxan ® ), where the risk of damage was 8.54 times greater than control (p = 0.01) (McDiarmid et al., 2010) . Based on studies that have shown an increased risk of cancer (Blair et al., 2001; Escobar, Smith, Vasishta, Hubbard, & Zhang, 2007; Fransman et al., 2014; Ratner et al., 2010) , and considering one of the fundamental theories of oncogenesis rests on the development of genetic mutations (Eggert, 2010), it would seem prudent to do whatever is necessary to prevent mutations whenever possible.
